Immunogen Inc. buy Piper Sandler
Start price
03.05.23
/
50%
€10.66
Target price
03.05.24
€14.47
Performance (%)
171.76%
End price
04.05.24
-
Summary
This prediction is currently being closed. The BUY prediction by Piper_Sandler for Immunogen Inc. has seen massive gains of 171.76%. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Immunogen Inc. | - | - | - | - |
| iShares Core DAX® | -2.796% | -1.396% | -0.221% | 48.430% |
| iShares Nasdaq 100 | -6.352% | -0.407% | 28.998% | 84.278% |
| iShares Nikkei 225® | -6.943% | -0.275% | 48.214% | 59.283% |
| iShares S&P 500 | -3.410% | 0.396% | 20.281% | 62.512% |
Comments by Piper_Sandler for this prediction
In the thread Immunogen Inc. diskutieren
ImmunoGen, Inc. (NASDAQ: IMGN) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $16.00 price target on the stock, up previously from $6.00.
Ratings data for IMGN provided by MarketBeat
In the thread Trading Immunogen Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten